+44 (0) 1698 534002
Contact

News

Advancements in generative AI: Implementation of an AI-assisted fragment library designer onto a widely accessible open-source platform

30 August 2022

BioAscent’s Associate Director of In Silico Discovery and Data Analysis, Dr Angelo Pugliese is co-author of a research a...

Read more

BioAscent invests in enhancing automated chromatography capabilities

21 August 2022

Delivering final compounds fast and efficiently to our customers is essential to help drive projects to meet key project...

Read more

A researcher’s event: Where would we be without science?

05 August 2022

On the 22nd July, BioAscent attended a researcher’s event hosted by the Glasgow Science Centre in celebration of the cen...

Read more

A Lighthouse journey leading to BioAscent: Local opportunities for talented and motivated early career scientists

07 July 2022

Applying the knowledge gained as an undergraduate, and adapting to full-time work can be difficult, particularly for tho...

Read more

Tough mudder 10km: A team challenge

05 July 2022

Our scientists applied their problem-solving and teamworking skills to a physical challenge on 3rd July- the tough mudde...

Read more

2022 Brain Health and Dementia Life Sciences Summit

24 June 2022

BioAscent’s Director of Biosciences, Dr Stuart McElroy recently delivered a presentation to delegates at the 2022 Brain...

Read more

Returning to Scotland: the best of both worlds

19 May 2022

Mark Grafton’s interest in chemistry was ignited at an early age when he was at school, leading him to follow a path in...

Read more

BioAscent invests in Incucyte Live-Cell Analysis System

17 March 2022

To improve our cell assay service offering, BioAscent has invested in a Sartorius Incucyte Live-Cell Analysis System whi...

Read more

Investment in Echo 650 increases assay ready plate capabilities

18 January 2022

BioAscent has invested in a new Echo 650 Series Acoustic Liquid Handler and Access Workstation to support the automation...

Read more

BioAscent granted Controlled Drug Licence

13 January 2022

BioAscent has been granted a Controlled Drug Licence, allowing the company to store and test scheduled substances on beh...

Read more

Integrated Drug Discovery

Science-led drug discovery

Compound Management

Connecting and accelerating your drug discovery

Medicinal Chemistry

Proven expertise in design and synthesis

In Silico Discovery

Accelerating drug design with computational expertise

Discovery Biology

Screening expertise across target classes

Get in Touch

Let's talk about how we can maximise your drug discovery success.

Contact